Outlook Therapeutics
OTLK
$8.74
Share price
-2.07%
Change (1 day)
646.58%
Change (1 year)
Categories
Outlook Therapeutics (OTLK) - Net assets
Net assets on the balance sheet as of December 2023 : -$24.35 M
According to Outlook Therapeutics
's latest financial reports the company has -$24.35 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Outlook Therapeutics - Net assets on balance sheet (from 2015 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $-14.44 M | -265.26% |
| 2022-09-30 | $8.73 M | 89.62% |
| 2021-09-30 | $4.6 M | 63.02% |
| 2020-09-30 | $2.82 M | -126.24% |
| 2019-09-30 | $-10.77 M | -48.25% |
| 2018-09-30 | $-20.82 M | -32.27% |
| 2017-09-30 | $-30.73 M | 493.99% |
| 2016-09-30 | $-5.18 M | -82.32% |
| 2015-09-30 | $-29.26 M | 0% |
| 2014-09-30 | $-29.26 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -125.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -429.69% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | 2,845.06% | 🇺🇸 USA |
 Novocure
NVCR | $0.36 B | -1,589.09% | Jersey |